Weathering A Biotech Storm - Global Pressures on Cell and Gene Therapies and How to Secure Your Biotech's CGT Future

Chair

Arthur Stril, Chief Business Officer, Cellectis

12pm Presentation

Warner Biddle, Global Head of Commercial, Kite, a Gilead Company

12.15pm Presentation: Accelerating Time to IND and Eliminating Delays and Bottlenecks to Commercial Scale Manufacturing

• Accelerate time to IND and clinical readouts by leveraging standardized Cell Shuttle process templates
• Early adoption of automated, end-to-end manufacturing technologies eliminates delays and bottlenecks in achieving the required scale to meet the total patient demand

Fabian Gerlinghaus, Chief Executive Officer, Cellares

12.30pm Fireside Chat

Raphael Ognar, Chief Executive Officer, NKILT

12.45pm Presentation Title: Charting a Course through Payer Engagement, Provider Partnerships, and Integration Data Management for CGTs

• Understand opportunities and challenges to optimize market access strategy
• Build trust and a collaborative partnership with healthcare providers
• Leverage technologies to improve data collection, analysis, and integration

Lung-I Cheng, Vice President and Head of Cell and Gene Therapy, Cencora World Courier